Brain Advance Access originally published online on June 30, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 127, No. 9, 1917-1927,
September 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh219
The regulatory role of natural killer cells in multiple sclerosis
1 Department of Immunology, National Institute ofNeuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502 and 2 Department of Bioregulation, Leprosy Research Center, National Institute of Infectious Diseases, 4-2-1 Aoba, Higashimurayama, Tokyo 189-0002, Japan
Correspondence to: Takashi Yamamura, Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan E-mail: yamamura{at}ncnp.go.jp
Multiple sclerosis is a chronic demyelinating disease of presumed autoimmune pathogenesis. The patients with multiple sclerosis typically shows alternating relapse and remission in the early stage of illness. We previously found that in the majority of multiple sclerosis patients in a state of remission, natural killer (NK) cells contain unusually high frequencies of the cells expressing CD95 (Fas) on their surface (>36.0%). Here we report that in such ‘CD95+ NK-high’ patients, NK cells may actively suppress potentially pathogenic autoimmune T cells that can mediate the inflammatory responses in the CNS. Using peripheral blood mononuclear cells (PBMCs) derived from ‘CD95+ NK-high’ or ‘CD95+ NK-low’ multiple sclerosis in a state of remission, we studied the effect of NK cell depletion on the memory T cell response to myelin basic protein (MBP), a major target antigen of multiple sclerosis. When we stimulated PBMCs of the ‘CD95+ NK-high’ multiple sclerosis after depleting CD56+ NK cells, a significant proportion of CD4+ T cells (1/2000 to 1/200) responded rapidly to MBP by secreting interferon (IFN)-
, whereas such a rapid T cell response to MBP could not be detected in the presence of NK cells. Nor did we detect the memory response to MBP in the ‘CD95+ NK-low’ multiple sclerosis patients in remission or healthy subjects, regardless of whether NK cells were depleted or not. Depletion of cells expressing CD16, another NK cell marker, also caused IFN- secretion from MBP-reactive CD4+ T cells in the PBMCs from ‘CD95+ NK-high’ multiple sclerosis. Moreover, we showed that NK cells from ‘CD95+ NK-high’ multiple sclerosis could inhibit the antigen-driven secretion of IFN- by autologous MBP-specific T cell clones in vitro. These results indicate that NK cells may regulate activation of autoimmune memory T cells in an antigen non-specific fashion to maintain the clinical remission in ‘CD95+ NK-high’ multiple sclerosis patients.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y Miyazaki, K Iwabuchi, S Kikuchi, T Fukazawa, M Niino, M Hirotani, H Sasaki, and K Onoe Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1044 - 1055. [Abstract] [PDF]
|
|
|
|
 |
|
 P. L. De Jager, E. Rossin, S. Pyne, P. Tamayo, L. Ottoboni, V. Viglietta, M. Weiner, D. Soler, E. Izmailova, L. Faron-Yowe, et al. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells Brain, July 1, 2008; 131(7): 1701 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Galazka, A. Jurewicz, W. Orlowski, M. Stasiolek, C. F. Brosnan, C. S. Raine, and K. Selmaj EAE Tolerance Induction with Hsp70-Peptide Complexes Depends on H60 and NKG2D Activity J. Immunol., October 1, 2007; 179(7): 4503 - 4512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakuishi, S. Oki, M. Araki, S. A. Porcelli, S. Miyake, and T. Yamamura Invariant NKT Cells Biased for IL-5 Production Act as Crucial Regulators of Inflammation J. Immunol., September 15, 2007; 179(6): 3452 - 3462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gattenloehner, S. Chuvpilo, C. Langebrake, D. Reinhardt, H.-K. Muller-Hermelink, E. Serfling, A. Vincent, and A. Marx Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression Blood, September 15, 2007; 110(6): 2027 - 2033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Aranami, S. Miyake, and T. Yamamura Differential Expression of CD11c by Peripheral Blood NK Cells Reflects Temporal Activity of Multiple Sclerosis J. Immunol., October 15, 2006; 177(8): 5659 - 5667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Fainardi, R Rizzo, L Melchiorri, M Castellazzi, E Paolino, M R Tola, E Granieri, and O R Baricordi Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis Multiple Sclerosis, February 1, 2006; 12(1): 2 - 12. [Abstract] [PDF]
|
|
|
|
|
|
G. Galazka, M. Stasiolek, A. Walczak, A. Jurewicz, A. Zylicz, C. F. Brosnan, C. S. Raine, and K. W. Selmaj Brain-Derived Heat Shock Protein 70-Peptide Complexes Induce NK Cell-Dependent Tolerance to Experimental Autoimmune Encephalomyelitis J. Immunol., February 1, 2006; 176(3): 1588 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Beeton and K. G. Chandy Potassium Channels, Memory T Cells, and Multiple Sclerosis Neuroscientist, December 1, 2005; 11(6): 550 - 562. [Abstract] [PDF]
|
|
|
|
|
|
P. P. Trivedi, P. C. Roberts, N. A. Wolf, and R. H. Swanborg NK Cells Inhibit T Cell Proliferation via p21-Mediated Cell Cycle Arrest J. Immunol., April 15, 2005; 174(8): 4590 - 4597. [Abstract] [Full Text] [PDF]
|
|